Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Life Insurance Co ( (HK:2628) ) just unveiled an announcement.
China Life Insurance Company Limited plans to contribute RMB4 billion as a limited partner to a new RMB5.0515 billion investment partnership alongside Pudong Venture Capital, Guotou Leading and China Life Infrastructure, with Chuangzhi Herui acting as general partner and Lingzhiying Shanghai as special limited partner, and China Life Capital appointed as manager. The transaction, classified as a connected transaction under Hong Kong listing rules due to the involvement of China Life’s controlling shareholder CLIC and its subsidiaries, is subject only to reporting and announcement requirements, with management fees falling below disclosure thresholds, and the partnership agreements are expected to be executed by 30 June 2026, signaling an increased allocation to partnership-based investments within the group structure without requiring independent shareholder approval.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$39.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Company Limited is one of China’s largest life insurers, offering a broad range of life insurance and related financial products and services. Listed in Hong Kong, the company focuses on the mainland Chinese market and operates within a wider group structure headed by China Life Insurance (Group) Company (CLIC), which holds a controlling stake and manages various investment and infrastructure-focused subsidiaries.
Average Trading Volume: 63,541,324
Technical Sentiment Signal: Buy
Current Market Cap: HK$1375.2B
For an in-depth examination of 2628 stock, go to TipRanks’ Overview page.